← Back to Search

Device

taVNS for Dyslexia

N/A

Waitlist Available

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

Study Summary

This trial will test if a device sending low-level electrical pulses to the ear can help teenagers with dyslexia learn novel letters. It will look at how the brain responds to this device and how the device affects learning.

Who is the study for?

This trial is for adolescents with dyslexia who can read at a certain level (scores above or below 90 on reading measures) and have normal non-verbal IQ. It's not for those with other neurological conditions like autism or epilepsy, nor for those taking medications besides ADHD prescriptions.Check my eligibility

What is being tested?

The study tests if taVNS, a low-level nerve stimulation given during letter-learning sessions, helps improve reading skills in dyslexic teens. Participants will receive either real taVNS or sham (fake) treatment to see which is more effective.See study design

What are the potential side effects?

Since this involves low-level nerve stimulation, potential side effects might include discomfort at the site of stimulation. However, as it's a pilot study focused on feasibility and tolerance, detailed side effects are being evaluated.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adverse events

Compliance

Secondary outcome measures

Automaticity

Decoding

Letter ID

Other outcome measures

fMRI

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Active taVNSExperimental Treatment1 Intervention

Participants will receive custom current at 5 Hz to the left auricular branch of the vagus nerve while learning new letter-sound relationships.

Group II: Sham taVNSPlacebo Group1 Intervention

Participants will undergo current thresholding but device will be turned off without their knowledge during the training.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,340 Previous Clinical Trials

715,596 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the study admit participants aged below thirty?

"According to the trial's requirements, those aged between 10 and 12 can be admitted into this study."

Answered by AI

For whom would this clinical research be suitable?

"The current clinical trial cohorts are open to children aged between 10 and 12 who have dyslexia. A total of 120 participants will be accepted for this study."

Answered by AI

Does this experiment currently require new participants?

"From the clinicaltrials.gov website, it is evident that no more patients are being recruited for this particular medical trial at present. This investigation was first posted on December 1st 2023 and has been modified as recently as November 7th 2023. However, there are presently 21 other related studies actively recruiting volunteers to take part in their research efforts."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

taVNS for Letter Learning in Dyslexia

2024. "taVNS for Letter Learning in Dyslexia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06127550.

All > Dyslexia